UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000039318
Receipt No. R000044846
Scientific Title A verification test of psychological and physiological effects of aroma or intake of coffee.
Date of disclosure of the study information 2020/08/31
Last modified on 2020/10/09 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A verification test of psychological and physiological effects of aroma or intake of coffee.
Acronym A verification test of psychological and physiological effects of aroma or intake of coffee.
Scientific Title A verification test of psychological and physiological effects of aroma or intake of coffee.
Scientific Title:Acronym A verification test of psychological and physiological effects of aroma or intake of coffee.
Region
Japan

Condition
Condition Healthy adults
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To verify psychological and physiological effect of coffee aroma, and psychological and physiological change by intake coffee.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes *Evaluation of autonomic nervous system, by iris measurement, skin temperature measurement and heart rate change
* Evaluation of parasympathetic nervous system, by measurement for function of field of view and stabilometry
*Flicker test
Key secondary outcomes *POMS2 short version
*VAS questionnaire

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Resting more than 10min- measurements and questionnaires- suctioning coffee aroma- measurements and questionnaires- intake coffee- resting- measurements and questionnaires- resting- measurements and questionnaires
Interventions/Control_2 Resting more than 10min- measurements and questionnaires- suctioning water aroma- measurements and questionnaires- intake water- resting- measurements and questionnaires- resting- measurements and questionnaires
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Males and female who are students of NIHON UNIVERSITY aged more than 20 years when informed consent.
2. Subjects who are able to intake coffee.
3. Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study.
Key exclusion criteria 1.Subjects who don't good at coffee aroma
2. Subjects who have smoking habit.
3. Subjects who are cold-sensitive constitution. (including subjects like that who feel cold on their hands and foots even in summer)
4. Subjects who are receiving medication due to treatment of disease.
5. In a past month, subjects who have had custom of taking or applying medicine for the treatment of diseases. (Except for cold but include for pollen allergy.)
6. Subjects who have stuffy nose such as allergic rhinitis, or subjects who are not able to determine aroma.
7. Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood.
8. Pregnant or expected pregnant, or lactating women.
9. Subjects who have symptom of dermatologic disease such as atopic dermatitis.
10. Subjects who feel pain in their knee, or subjects who feel pain or discomfort when bent their knee.
11. Subjects who have undergone surgery on investigation objective portion within the past 6 months.
12. Subjects who are participating the other clinical tests. Subjects who participated within a month prior to the current study and/or who plan to participate the other clinical tests.
13. Other who is determined ineligible by investigator.
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Motoko
Middle name
Last name Ohata
Organization NIHON UNIVERSITY
Division name College of Bioresource Science
Zip code 252-0880
Address 1866 Kameino, Fujisawa-shi, Kanagawa 252-0880 Japan
TEL 0466-84-3987
Email Oohata.motoko@mihon-u.ac.jp

Public contact
Name of contact person
1st name Yukihiro
Middle name
Last name Yada
Organization University of Tsukuba, School of Integrative
Division name Global Majors
Zip code 305-8577
Address 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577 Japan
TEL 029-853-7344
Homepage URL
Email yada.yukihiro.gb@u.tsukuba.ac.jp

Sponsor
Institute NIHON UNIVERSITY
Institute
Department

Funding Source
Organization NIHON UNIVERSITY
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor University of Tsukuba, School of Integrative
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board of Chiyoda Paramedical Care Clinic
Address 2F Chushin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan
Tel 03-5297-5548
Email IRB@cpcc.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 08 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 20
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 08 Month 16 Day
Date of IRB
2019 Year 08 Month 16 Day
Anticipated trial start date
2019 Year 09 Month 01 Day
Last follow-up date
2020 Year 01 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 01 Month 30 Day
Last modified on
2020 Year 10 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044846